1. Home
  2. KURA vs ARRY Comparison

KURA vs ARRY Comparison

Compare KURA & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • ARRY
  • Stock Information
  • Founded
  • KURA 2014
  • ARRY 1989
  • Country
  • KURA United States
  • ARRY United States
  • Employees
  • KURA N/A
  • ARRY N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • ARRY Semiconductors
  • Sector
  • KURA Health Care
  • ARRY Technology
  • Exchange
  • KURA Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • KURA 793.2M
  • ARRY 977.0M
  • IPO Year
  • KURA N/A
  • ARRY 2020
  • Fundamental
  • Price
  • KURA $7.26
  • ARRY $6.75
  • Analyst Decision
  • KURA Strong Buy
  • ARRY Buy
  • Analyst Count
  • KURA 11
  • ARRY 22
  • Target Price
  • KURA $27.89
  • ARRY $12.34
  • AVG Volume (30 Days)
  • KURA 1.8M
  • ARRY 5.3M
  • Earning Date
  • KURA 02-25-2025
  • ARRY 02-25-2025
  • Dividend Yield
  • KURA N/A
  • ARRY N/A
  • EPS Growth
  • KURA N/A
  • ARRY N/A
  • EPS
  • KURA N/A
  • ARRY N/A
  • Revenue
  • KURA N/A
  • ARRY $982,190,000.00
  • Revenue This Year
  • KURA N/A
  • ARRY N/A
  • Revenue Next Year
  • KURA $233.30
  • ARRY $23.99
  • P/E Ratio
  • KURA N/A
  • ARRY N/A
  • Revenue Growth
  • KURA N/A
  • ARRY N/A
  • 52 Week Low
  • KURA $6.98
  • ARRY $5.15
  • 52 Week High
  • KURA $24.17
  • ARRY $16.22
  • Technical
  • Relative Strength Index (RSI)
  • KURA 17.38
  • ARRY 57.68
  • Support Level
  • KURA $6.98
  • ARRY $6.05
  • Resistance Level
  • KURA $8.88
  • ARRY $7.16
  • Average True Range (ATR)
  • KURA 0.33
  • ARRY 0.38
  • MACD
  • KURA 0.05
  • ARRY 0.09
  • Stochastic Oscillator
  • KURA 13.40
  • ARRY 73.03

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: